FLT3 Inhibitors in Mutant FLT3 AML

被引：0
|
作者：
Stone, Richard M. [1 ]
Garcia, Jacqueline [1 ]
机构：
[1] Harvard Med Sch, Dana Farber Canc Inst, Dept Med Oncol, 450 Brookline Ave,D2053, Boston, MA 02215 USA
来源：
ANNALS OF HEMATOLOGY | 2017年 / 96卷
关键词：
ACUTE MYELOID-LEUKEMIA; NORMAL CYTOGENETICS; CONTROLLED-TRIAL; SORAFENIB; YOUNGER; PLACEBO;
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：S36 / S37
页数：2
相关论文
共 50 条
  • [21] Novel FLT3 Inhibitors and Targeted Therapies in AML
    Levis, M.
    ANNALS OF HEMATOLOGY, 2015, 94 : S35 - S37
  • [22] Can FLT3 inhibitors overcome resistance in AML?
    Tam, Winnie F.
    Gilliland, Gary
    BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY, 2008, 21 (01) : 13 - 20
  • [23] FLT3 ligand impedes the efficacy of FLT3 inhibitors in vitro and in vivo
    Sato, Takashi
    Yang, Xiaochuan
    Knapper, Steven
    White, Paul
    Smith, B. Douglas
    Galkin, Steven
    Small, Donald
    Burnett, Alan
    Levis, Mark
    BLOOD, 2011, 117 (12) : 3286 - 3293
  • [24] FLT3 inhibition and mechanisms of drug resistance in mutant FLT3-positive AML
    Weisberg, Ellen
    Barrett, Rosemary
    Liu, Qingsong
    Stone, Richard
    Gray, Nathanael
    Griffin, James D.
    DRUG RESISTANCE UPDATES, 2009, 12 (03) : 81 - 89
  • [25] Inhibitors of class I HDACs and of FLT3 combine synergistically against leukemia cells with mutant FLT3
    Vanessa Wachholz
    Al-Hassan M. Mustafa
    Yanira Zeyn
    Sven J. Henninger
    Mandy Beyer
    Melanie Dzulko
    Andrea Piée-Staffa
    Christina Brachetti
    Patricia S. Haehnel
    Andreas Sellmer
    Siavosh Mahboobi
    Thomas Kindler
    Walburgis Brenner
    Teodora Nikolova
    Oliver H. Krämer
    Archives of Toxicology, 2022, 96 : 177 - 193
  • [26] Inhibitors of class I HDACs and of FLT3 combine synergistically against leukemia cells with mutant FLT3
    Wachholz, Vanessa
    Mustafa, Al-Hassan M.
    Zeyn, Yanira
    Henninger, Sven J.
    Beyer, Mandy
    Dzulko, Melanie
    Piee-Staffa, Andrea
    Brachetti, Christina
    Haehnel, Patricia S.
    Sellmer, Andreas
    Mahboobi, Siavosh
    Kindler, Thomas
    Brenner, Walburgis
    Nikolova, Teodora
    Kramer, Oliver H.
    ARCHIVES OF TOXICOLOGY, 2022, 96 (01) : 177 - 193
  • [27] Analysis of flt3 in Adult AML
    Adnan, Shady
    Kandeel, Eman Z.
    Ghareeb, Mohammed
    Eldessouki, Ihab A.
    BLOOD, 2015, 126 (23)
  • [28] AML and FLT3: An Update on FDA-approved or Under Review Kinase Inhibitors Targeting FLT3 Kinase
    El-Deen, Nada Alaa
    Dokla, Eman M. E.
    Jaballah, Maiy Y.
    Abouzid, Khaled A. M.
    Serya, Rabah A. T.
    EGYPTIAN JOURNAL OF CHEMISTRY, 2024, 67 (05): : 529 - 553
  • [29] FLT3 gene mutations in AML
    Mills, KI
    Gilkes, AF
    Walsh, V
    Sweeney, M
    Austin, SJ
    Gale, RE
    BRITISH JOURNAL OF HAEMATOLOGY, 2005, 129 : 29 - 29
  • [30] Role of Biomarkers in FLT3 AML
    Wei, Jiao
    Hui, Ai-Min
    Nitika
    CANCERS, 2022, 14 (05)
12345